Quotient appoints Christopher Lindop as CFO
Mr. Lindop joins Quotient with more than a decade of financial leadership experience within high-growth diagnostic and blood management companies.
Most recently, Mr. Lindop served as Chief Financial Officer and Executive Vice President of Business Development at Haemonetics Corporation.
Prior to joining Haemonetics in January 2007, he served as Chief Financial Officer at Inverness Medical Innovations, now Alere Inc. He was a Partner at both Arthur Andersen and Ernst & Young.
Mr. Lindop currently serves on the Board of Directors at Parexel International.
He holds a B.A. in Business from the University of Strathclyde (Scotland).